Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases. Through internal development and acquisition of key technologies, the company has established competencies in areas such as molecular biology, cell biology, genomics, protein biochemistry, medicinal chemistry and pharmacology. Some of Athersys pharmaceutical development programs are focused on the development of novel treatments for obesity, certain cognitive disorders and asthma. The company has established multiple programs in the area of regenerative medicine, applying a powerful and proprietary adult stem cell technology and a blend of other technologies. Through internal efforts, strategic partnerships and collaborations with leading clinical and basic research institutions, Athersys creates therapeutic approaches to treat cardiovascular disease, stroke, blood and immune system disorders and diabetes. Established in 1995, the company has its headquarters in Cleveland and another location in Minneapolis.
Partial Data by Infogroup (c) 2024. All rights reserved.